Take Two: US inflation rises; China trade surplus nears $1trn
- 20 January 2025 (3 min read)
What do you need to know?
US annual inflation rose for the third consecutive month in December, to 2.9% from 2.7% in November reflecting increased energy prices. Core inflation, which excludes energy and food, edged unexpectedly lower to 3.2% from 3.3% previously. Currently AXA IM expects the Federal Reserve to cut interest rates once more in March, before pausing its easing cycle until the second half of 2026. Elsewhere, Eurozone annual inflation was confirmed at 2.4% in December, up from 2.2% in November. In the UK inflation unexpectedly fell to 2.5% year-on-year in December from 2.6%, while core inflation eased to 3.2% from 3.5%, boosting hopes of an interest rate cut next month.
Around the world
China’s economy grew 5.4% in the fourth quarter (Q4) from a year earlier, the fastest pace in six quarters, lifting GDP growth to 5% for the year - in line with its target. Strong growth in exports helped boost the world’s second-largest economy - China’s annual trade surplus neared a record US$1trn in 2024, as its exports rose ahead of expected US trade tariffs while weak domestic demand held back imports. In December, exports rose 10.7% from a year earlier to $104.8bn, while imports grew 1%, resulting in a $992bn surplus for the year. However, there are concerns that tariffs will reduce exports in future, removing a key driver of China’s economic growth.
Figure in focus: 19 million
Growing digital access is expected to create 19 million jobs by 2030, according to the World Economic Forum’s (WEF) Future of Jobs Report 2025. At the same time, it is expected to replace around nine million roles. The report found that 60% of employers expect broadening digital access to transform their businesses in the next five years, with three key technologies - robotics and automation, energy generation and storage, as well as artificial intelligence and information processing – predicted to have the biggest impact.
Words of wisdom
PFAS - Per- and polyfluoroalkyl substances (PFAS), commonly referred to as ‘forever chemicals’, are human-made chemicals which can take thousands of years to break down. They are used in a wide range of consumer products and industrial processes, from non-stick cookware and waterproof clothing to cleaning products – some studies have linked some PFAS to harmful health effects. A recent report from the Forever Lobbying Project found that the cost of cleaning up pollution from these toxic chemicals could reach more than £1.6trn across the UK and Europe over a 20-year period. Although some types of PFAS have been banned, there are calls for greater regulation on a global scale.
What's coming up?
All eyes will be on the US on Monday as Donald Trump is inaugurated as President, marking the beginning of his second term in office. On the same day the WEF annual meeting begins in Davos, Switzerland. On Tuesday, the Eurozone’s ZEW Economic Sentiment Index is published while Canada reports its latest inflation data, followed by Japan on Friday. The Bank of Japan also meets to decide on monetary policy with a two-day meeting on Thursday/Friday - policymakers chose to hold rates steady at 0.25% in December and AXA IM expects a 0.25% hike at this meeting. In addition, on Friday, flash Purchasing Managers’ Index data is released for the Eurozone, US, UK and Japan.
Disclaimer
This website is published by AXA Investment Managers Asia Limited (“AXA IM HK”), an entity licensed by the Securities and Futures Commission of Hong Kong (“SFC”), for general circulation and informational purposes only. It does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy, sell or enter into any transactions in respect of any investments, products or services, and should not be considered as solicitation or investment, legal, tax or any other advice, a recommendation for an investment strategy or a personalised recommendation to buy or sell securities under any applicable law or regulation. It has been prepared without taking into account the specific personal circumstances, investment objectives, financial situation, investment knowledge or particular needs of any particular person and may be subject to change at any time without notice. Offering may be made only on the basis of the information disclosed in the relevant offering documents. Please consult independent financial or other professional advisers if you are unsure about any information contained herein.
Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee such opinions, estimates and forecasts made will come to pass. Actual results of operations and achievements may differ materially. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Information herein may be obtained from sources believed to be reliable. AXA IM HK has reasonable belief that such information is accurate, complete and up-to-date. To the maximum extent permitted by law, AXA IM HK, its affiliates, directors, officers or employees take no responsibility for the data provided by third party, including the accuracy of such data. This material does not contain sufficient information to support an investment decision. References to companies (if any) are for illustrative purposes only and should not be viewed as investment recommendations or solicitations.
All investment involves risk, including the loss of capital. The value of investments and the income from them can fluctuate and that past performance is no guarantee of future returns, investors may not get back the amount originally invested. Investors should not make any investment decision based on this material alone.
Some of the services listed on this Website may not be available for offer to retail investors.
This Website has not been reviewed by the SFC. © 2025 AXA Investment Managers. All rights reserved.